COMMUN BIOL 润色咨询

Communications Biology

出版年份：暂无数据 年文章数：3101 投稿命中率： 开通期刊会员，数据随心看

出版周期：暂无数据 自引率：暂无数据 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2204152, encodeId=93da2204152fb, content=请问大家一般是几个审稿人呀？一定要3个审稿人的意见编辑才会做决定吗？我在research square上看到3月份邀请了5个审稿人，2个同意并审完了（1个3月底，1个4月初）但是现在5月份了状态还在under review，这里也没有显示review3 agree的信息。<br>Review <a href='/topic/show?id=1efd114362fc' target=_blank style='color:#2F92EE;'>#2 received<br>Review #</a>1 received<br>Reviewer <a href='/topic/show?id=24c6114363d5' target=_blank style='color:#2F92EE;'>#2 agreed<br>Reviewer #</a>1 agreed<br>5 reviewer(s) invited<br>Invitations sent on 13 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=7, topicName=null, topicId=null, topicList=[TopicDto(id=114362, encryptionId=1efd114362fc, topicName=2 received<br>Review ), TopicDto(id=114363, encryptionId=24c6114363d5, topicName=2 agreed<br>Reviewer )], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86182534474, createdName=流离岁月, createdTime=Sat May 11 21:50:44 CST 2024, time=2024-05-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1247789, encodeId=32eb124e78951, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：第二轮<br>Waiting for Revision 6th Sep 22<br>Decision Made 6th Sep 22<br>Editor Review Started 14th Jul 22<br>Initial Manuscript Review Started 13th Jul 22<br>Editor Assigned 13th Jul 22<br>Submission 11th Jul 22<br>第一轮<br>Revision Received 11th Jul 22<br>Waiting for Revision 26th May 22<br>Decision Made 25th May 22<br>Editor Review Started 7th Apr 22<br>Initial Manuscript Review Started 28th Mar 22<br>Editor Assigned 25th Mar 22<br>Submission 23rd Mar 22<br><br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06461617618, createdName=keepworking, createdTime=Wed Sep 07 22:39:09 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198089, encodeId=314a2198089dd, content=we cannot accept the manuscript for publication, but would be interested in considering a revised version that addresses these serious concerns.这一意思是大修吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04906564334, createdName=ms5000000011937101, createdTime=Fri Apr 12 07:05:33 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2208056, encodeId=63c12208056d4, content=偏重的研究方向：基因组学<br>经验分享：6月1日提交，submission状态，希望好运！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab498294868, createdName=ms7000000214967727, createdTime=Mon Jun 03 14:14:56 CST 2024, time=2024-06-03, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2198308, encodeId=3d5221983088d, content=4.7提交，今天还是Submission，更新接好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96c69031712, createdName=ms6000002090135599, createdTime=Sat Apr 13 20:26:12 CST 2024, time=2024-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2206509, encodeId=2e9d220650922, content=等的心急，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsmALpODGnWib5UaDNI6ztgdmKt9ib3ibKROqTEpGzjvlLbbTLHod3OMBdlb0fCVKtGlvodJCkmsL7Q/132, createdBy=d0d95098090, createdName=ms1469747388241577, createdTime=Sat May 25 07:30:36 CST 2024, time=2024-05-25, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2195546, encodeId=7d7c219554630, content=偏重的研究方向：眼科;角膜<br>经验分享：第一次尝试。<br>更新攒人品拉！<br>Initial Manuscript Review Started 26th Mar 24<br>Editor Assigned 25th Mar 24<br>Submission 20th Mar 24<br>希望可以顺利<br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f75577556, createdName=ms7000000088062990, createdTime=Tue Mar 26 22:21:39 CST 2024, time=2024-03-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189505, encodeId=052d218950581, content=Editor assigned已经持续5天了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84c19170672, createdName=ms9000000584736868, createdTime=Mon Feb 26 19:54:36 CST 2024, time=2024-02-26, status=1, ipAttribution=慕尼黑), GetPortalCommentsPageByObjectIdResponse(id=2201987, encodeId=d607220198e99, content=目前的进度：<br>Initial Manuscript Review Started 30th Apr 24<br>Editor Assigned 25th Apr 24<br>Submission 17th Apr 24<br>还是不太搞得懂这个杂志的外审是哪个阶段啊？这个initial review算吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c9e8711556, createdName=ms3000002086500682, createdTime=Mon May 06 11:46:59 CST 2024, time=2024-05-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206135, encodeId=94122206135f2, content=审稿速度:24.0 | 投稿命中率:25.0<br>偏重的研究方向：昆虫共生菌<br>经验分享：Initial Manuscript Review Started 14th May 24<br>Editor Assigned 8th May 24<br>Submission 26th Apr 24<br>马上一个月了，请问intital manuscript review started持续十天是不是要悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d1e9163807, createdName=ms4000001806408431, createdTime=Thu May 23 09:08:10 CST 2024, time=2024-05-23, status=1, ipAttribution=浙江省)]
    2024-05-11 流离岁月 来自浙江省

    请问大家一般是几个审稿人呀？一定要3个审稿人的意见编辑才会做决定吗？我在research square上看到3月份邀请了5个审稿人，2个同意并审完了（1个3月底，1个4月初）但是现在5月份了状态还在under review，这里也没有显示review3 agree的信息。
    Review #2 received
    Review #    1 received
    Reviewer #2 agreed
    Reviewer #    1 agreed
    5 reviewer(s) invited
    Invitations sent on 13 Mar, 2024

    7

    展开7条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2204152, encodeId=93da2204152fb, content=请问大家一般是几个审稿人呀？一定要3个审稿人的意见编辑才会做决定吗？我在research square上看到3月份邀请了5个审稿人，2个同意并审完了（1个3月底，1个4月初）但是现在5月份了状态还在under review，这里也没有显示review3 agree的信息。<br>Review <a href='/topic/show?id=1efd114362fc' target=_blank style='color:#2F92EE;'>#2 received<br>Review #</a>1 received<br>Reviewer <a href='/topic/show?id=24c6114363d5' target=_blank style='color:#2F92EE;'>#2 agreed<br>Reviewer #</a>1 agreed<br>5 reviewer(s) invited<br>Invitations sent on 13 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=7, topicName=null, topicId=null, topicList=[TopicDto(id=114362, encryptionId=1efd114362fc, topicName=2 received<br>Review ), TopicDto(id=114363, encryptionId=24c6114363d5, topicName=2 agreed<br>Reviewer )], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86182534474, createdName=流离岁月, createdTime=Sat May 11 21:50:44 CST 2024, time=2024-05-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1247789, encodeId=32eb124e78951, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：第二轮<br>Waiting for Revision 6th Sep 22<br>Decision Made 6th Sep 22<br>Editor Review Started 14th Jul 22<br>Initial Manuscript Review Started 13th Jul 22<br>Editor Assigned 13th Jul 22<br>Submission 11th Jul 22<br>第一轮<br>Revision Received 11th Jul 22<br>Waiting for Revision 26th May 22<br>Decision Made 25th May 22<br>Editor Review Started 7th Apr 22<br>Initial Manuscript Review Started 28th Mar 22<br>Editor Assigned 25th Mar 22<br>Submission 23rd Mar 22<br><br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06461617618, createdName=keepworking, createdTime=Wed Sep 07 22:39:09 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198089, encodeId=314a2198089dd, content=we cannot accept the manuscript for publication, but would be interested in considering a revised version that addresses these serious concerns.这一意思是大修吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04906564334, createdName=ms5000000011937101, createdTime=Fri Apr 12 07:05:33 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2208056, encodeId=63c12208056d4, content=偏重的研究方向：基因组学<br>经验分享：6月1日提交，submission状态，希望好运！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab498294868, createdName=ms7000000214967727, createdTime=Mon Jun 03 14:14:56 CST 2024, time=2024-06-03, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2198308, encodeId=3d5221983088d, content=4.7提交，今天还是Submission，更新接好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96c69031712, createdName=ms6000002090135599, createdTime=Sat Apr 13 20:26:12 CST 2024, time=2024-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2206509, encodeId=2e9d220650922, content=等的心急，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsmALpODGnWib5UaDNI6ztgdmKt9ib3ibKROqTEpGzjvlLbbTLHod3OMBdlb0fCVKtGlvodJCkmsL7Q/132, createdBy=d0d95098090, createdName=ms1469747388241577, createdTime=Sat May 25 07:30:36 CST 2024, time=2024-05-25, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2195546, encodeId=7d7c219554630, content=偏重的研究方向：眼科;角膜<br>经验分享：第一次尝试。<br>更新攒人品拉！<br>Initial Manuscript Review Started 26th Mar 24<br>Editor Assigned 25th Mar 24<br>Submission 20th Mar 24<br>希望可以顺利<br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f75577556, createdName=ms7000000088062990, createdTime=Tue Mar 26 22:21:39 CST 2024, time=2024-03-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189505, encodeId=052d218950581, content=Editor assigned已经持续5天了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84c19170672, createdName=ms9000000584736868, createdTime=Mon Feb 26 19:54:36 CST 2024, time=2024-02-26, status=1, ipAttribution=慕尼黑), GetPortalCommentsPageByObjectIdResponse(id=2201987, encodeId=d607220198e99, content=目前的进度：<br>Initial Manuscript Review Started 30th Apr 24<br>Editor Assigned 25th Apr 24<br>Submission 17th Apr 24<br>还是不太搞得懂这个杂志的外审是哪个阶段啊？这个initial review算吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c9e8711556, createdName=ms3000002086500682, createdTime=Mon May 06 11:46:59 CST 2024, time=2024-05-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206135, encodeId=94122206135f2, content=审稿速度:24.0 | 投稿命中率:25.0<br>偏重的研究方向：昆虫共生菌<br>经验分享：Initial Manuscript Review Started 14th May 24<br>Editor Assigned 8th May 24<br>Submission 26th Apr 24<br>马上一个月了，请问intital manuscript review started持续十天是不是要悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d1e9163807, createdName=ms4000001806408431, createdTime=Thu May 23 09:08:10 CST 2024, time=2024-05-23, status=1, ipAttribution=浙江省)]
    2022-09-07 keepworking

    审稿速度:6.0 | 投稿命中率:25.0
    经验分享：第二轮
    Waiting for Revision 6th Sep 22
    Decision Made 6th Sep 22
    Editor Review Started 14th Jul 22
    Initial Manuscript Review Started 13th Jul 22
    Editor Assigned 13th Jul 22
    Submission 11th Jul 22
    第一轮
    Revision Received 11th Jul 22
    Waiting for Revision 26th May 22
    Decision Made 25th May 22
    Editor Review Started 7th Apr 22
    Initial Manuscript Review Started 28th Mar 22
    Editor Assigned 25th Mar 22
    Submission 23rd Mar 22


    6

    展开6条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2204152, encodeId=93da2204152fb, content=请问大家一般是几个审稿人呀？一定要3个审稿人的意见编辑才会做决定吗？我在research square上看到3月份邀请了5个审稿人，2个同意并审完了（1个3月底，1个4月初）但是现在5月份了状态还在under review，这里也没有显示review3 agree的信息。<br>Review <a href='/topic/show?id=1efd114362fc' target=_blank style='color:#2F92EE;'>#2 received<br>Review #</a>1 received<br>Reviewer <a href='/topic/show?id=24c6114363d5' target=_blank style='color:#2F92EE;'>#2 agreed<br>Reviewer #</a>1 agreed<br>5 reviewer(s) invited<br>Invitations sent on 13 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=7, topicName=null, topicId=null, topicList=[TopicDto(id=114362, encryptionId=1efd114362fc, topicName=2 received<br>Review ), TopicDto(id=114363, encryptionId=24c6114363d5, topicName=2 agreed<br>Reviewer )], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86182534474, createdName=流离岁月, createdTime=Sat May 11 21:50:44 CST 2024, time=2024-05-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1247789, encodeId=32eb124e78951, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：第二轮<br>Waiting for Revision 6th Sep 22<br>Decision Made 6th Sep 22<br>Editor Review Started 14th Jul 22<br>Initial Manuscript Review Started 13th Jul 22<br>Editor Assigned 13th Jul 22<br>Submission 11th Jul 22<br>第一轮<br>Revision Received 11th Jul 22<br>Waiting for Revision 26th May 22<br>Decision Made 25th May 22<br>Editor Review Started 7th Apr 22<br>Initial Manuscript Review Started 28th Mar 22<br>Editor Assigned 25th Mar 22<br>Submission 23rd Mar 22<br><br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06461617618, createdName=keepworking, createdTime=Wed Sep 07 22:39:09 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198089, encodeId=314a2198089dd, content=we cannot accept the manuscript for publication, but would be interested in considering a revised version that addresses these serious concerns.这一意思是大修吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04906564334, createdName=ms5000000011937101, createdTime=Fri Apr 12 07:05:33 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2208056, encodeId=63c12208056d4, content=偏重的研究方向：基因组学<br>经验分享：6月1日提交，submission状态，希望好运！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab498294868, createdName=ms7000000214967727, createdTime=Mon Jun 03 14:14:56 CST 2024, time=2024-06-03, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2198308, encodeId=3d5221983088d, content=4.7提交，今天还是Submission，更新接好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96c69031712, createdName=ms6000002090135599, createdTime=Sat Apr 13 20:26:12 CST 2024, time=2024-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2206509, encodeId=2e9d220650922, content=等的心急，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsmALpODGnWib5UaDNI6ztgdmKt9ib3ibKROqTEpGzjvlLbbTLHod3OMBdlb0fCVKtGlvodJCkmsL7Q/132, createdBy=d0d95098090, createdName=ms1469747388241577, createdTime=Sat May 25 07:30:36 CST 2024, time=2024-05-25, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2195546, encodeId=7d7c219554630, content=偏重的研究方向：眼科;角膜<br>经验分享：第一次尝试。<br>更新攒人品拉！<br>Initial Manuscript Review Started 26th Mar 24<br>Editor Assigned 25th Mar 24<br>Submission 20th Mar 24<br>希望可以顺利<br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f75577556, createdName=ms7000000088062990, createdTime=Tue Mar 26 22:21:39 CST 2024, time=2024-03-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189505, encodeId=052d218950581, content=Editor assigned已经持续5天了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84c19170672, createdName=ms9000000584736868, createdTime=Mon Feb 26 19:54:36 CST 2024, time=2024-02-26, status=1, ipAttribution=慕尼黑), GetPortalCommentsPageByObjectIdResponse(id=2201987, encodeId=d607220198e99, content=目前的进度：<br>Initial Manuscript Review Started 30th Apr 24<br>Editor Assigned 25th Apr 24<br>Submission 17th Apr 24<br>还是不太搞得懂这个杂志的外审是哪个阶段啊？这个initial review算吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c9e8711556, createdName=ms3000002086500682, createdTime=Mon May 06 11:46:59 CST 2024, time=2024-05-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206135, encodeId=94122206135f2, content=审稿速度:24.0 | 投稿命中率:25.0<br>偏重的研究方向：昆虫共生菌<br>经验分享：Initial Manuscript Review Started 14th May 24<br>Editor Assigned 8th May 24<br>Submission 26th Apr 24<br>马上一个月了，请问intital manuscript review started持续十天是不是要悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d1e9163807, createdName=ms4000001806408431, createdTime=Thu May 23 09:08:10 CST 2024, time=2024-05-23, status=1, ipAttribution=浙江省)]
    2024-04-12 ms5000000011937101 来自江苏省

    we cannot accept the manuscript for publication, but would be interested in considering a revised version that addresses these serious concerns.这一意思是大修吗

    6

    展开6条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2204152, encodeId=93da2204152fb, content=请问大家一般是几个审稿人呀？一定要3个审稿人的意见编辑才会做决定吗？我在research square上看到3月份邀请了5个审稿人，2个同意并审完了（1个3月底，1个4月初）但是现在5月份了状态还在under review，这里也没有显示review3 agree的信息。<br>Review <a href='/topic/show?id=1efd114362fc' target=_blank style='color:#2F92EE;'>#2 received<br>Review #</a>1 received<br>Reviewer <a href='/topic/show?id=24c6114363d5' target=_blank style='color:#2F92EE;'>#2 agreed<br>Reviewer #</a>1 agreed<br>5 reviewer(s) invited<br>Invitations sent on 13 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=7, topicName=null, topicId=null, topicList=[TopicDto(id=114362, encryptionId=1efd114362fc, topicName=2 received<br>Review ), TopicDto(id=114363, encryptionId=24c6114363d5, topicName=2 agreed<br>Reviewer )], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86182534474, createdName=流离岁月, createdTime=Sat May 11 21:50:44 CST 2024, time=2024-05-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1247789, encodeId=32eb124e78951, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：第二轮<br>Waiting for Revision 6th Sep 22<br>Decision Made 6th Sep 22<br>Editor Review Started 14th Jul 22<br>Initial Manuscript Review Started 13th Jul 22<br>Editor Assigned 13th Jul 22<br>Submission 11th Jul 22<br>第一轮<br>Revision Received 11th Jul 22<br>Waiting for Revision 26th May 22<br>Decision Made 25th May 22<br>Editor Review Started 7th Apr 22<br>Initial Manuscript Review Started 28th Mar 22<br>Editor Assigned 25th Mar 22<br>Submission 23rd Mar 22<br><br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06461617618, createdName=keepworking, createdTime=Wed Sep 07 22:39:09 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198089, encodeId=314a2198089dd, content=we cannot accept the manuscript for publication, but would be interested in considering a revised version that addresses these serious concerns.这一意思是大修吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04906564334, createdName=ms5000000011937101, createdTime=Fri Apr 12 07:05:33 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2208056, encodeId=63c12208056d4, content=偏重的研究方向：基因组学<br>经验分享：6月1日提交，submission状态，希望好运！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab498294868, createdName=ms7000000214967727, createdTime=Mon Jun 03 14:14:56 CST 2024, time=2024-06-03, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2198308, encodeId=3d5221983088d, content=4.7提交，今天还是Submission，更新接好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96c69031712, createdName=ms6000002090135599, createdTime=Sat Apr 13 20:26:12 CST 2024, time=2024-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2206509, encodeId=2e9d220650922, content=等的心急，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsmALpODGnWib5UaDNI6ztgdmKt9ib3ibKROqTEpGzjvlLbbTLHod3OMBdlb0fCVKtGlvodJCkmsL7Q/132, createdBy=d0d95098090, createdName=ms1469747388241577, createdTime=Sat May 25 07:30:36 CST 2024, time=2024-05-25, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2195546, encodeId=7d7c219554630, content=偏重的研究方向：眼科;角膜<br>经验分享：第一次尝试。<br>更新攒人品拉！<br>Initial Manuscript Review Started 26th Mar 24<br>Editor Assigned 25th Mar 24<br>Submission 20th Mar 24<br>希望可以顺利<br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f75577556, createdName=ms7000000088062990, createdTime=Tue Mar 26 22:21:39 CST 2024, time=2024-03-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189505, encodeId=052d218950581, content=Editor assigned已经持续5天了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84c19170672, createdName=ms9000000584736868, createdTime=Mon Feb 26 19:54:36 CST 2024, time=2024-02-26, status=1, ipAttribution=慕尼黑), GetPortalCommentsPageByObjectIdResponse(id=2201987, encodeId=d607220198e99, content=目前的进度：<br>Initial Manuscript Review Started 30th Apr 24<br>Editor Assigned 25th Apr 24<br>Submission 17th Apr 24<br>还是不太搞得懂这个杂志的外审是哪个阶段啊？这个initial review算吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c9e8711556, createdName=ms3000002086500682, createdTime=Mon May 06 11:46:59 CST 2024, time=2024-05-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206135, encodeId=94122206135f2, content=审稿速度:24.0 | 投稿命中率:25.0<br>偏重的研究方向：昆虫共生菌<br>经验分享：Initial Manuscript Review Started 14th May 24<br>Editor Assigned 8th May 24<br>Submission 26th Apr 24<br>马上一个月了，请问intital manuscript review started持续十天是不是要悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d1e9163807, createdName=ms4000001806408431, createdTime=Thu May 23 09:08:10 CST 2024, time=2024-05-23, status=1, ipAttribution=浙江省)]
    2024-06-03 ms7000000214967727 来自福建省

    偏重的研究方向：基因组学
    经验分享：6月1日提交，submission状态，希望好运！！！

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2204152, encodeId=93da2204152fb, content=请问大家一般是几个审稿人呀？一定要3个审稿人的意见编辑才会做决定吗？我在research square上看到3月份邀请了5个审稿人，2个同意并审完了（1个3月底，1个4月初）但是现在5月份了状态还在under review，这里也没有显示review3 agree的信息。<br>Review <a href='/topic/show?id=1efd114362fc' target=_blank style='color:#2F92EE;'>#2 received<br>Review #</a>1 received<br>Reviewer <a href='/topic/show?id=24c6114363d5' target=_blank style='color:#2F92EE;'>#2 agreed<br>Reviewer #</a>1 agreed<br>5 reviewer(s) invited<br>Invitations sent on 13 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=7, topicName=null, topicId=null, topicList=[TopicDto(id=114362, encryptionId=1efd114362fc, topicName=2 received<br>Review ), TopicDto(id=114363, encryptionId=24c6114363d5, topicName=2 agreed<br>Reviewer )], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86182534474, createdName=流离岁月, createdTime=Sat May 11 21:50:44 CST 2024, time=2024-05-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1247789, encodeId=32eb124e78951, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：第二轮<br>Waiting for Revision 6th Sep 22<br>Decision Made 6th Sep 22<br>Editor Review Started 14th Jul 22<br>Initial Manuscript Review Started 13th Jul 22<br>Editor Assigned 13th Jul 22<br>Submission 11th Jul 22<br>第一轮<br>Revision Received 11th Jul 22<br>Waiting for Revision 26th May 22<br>Decision Made 25th May 22<br>Editor Review Started 7th Apr 22<br>Initial Manuscript Review Started 28th Mar 22<br>Editor Assigned 25th Mar 22<br>Submission 23rd Mar 22<br><br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06461617618, createdName=keepworking, createdTime=Wed Sep 07 22:39:09 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198089, encodeId=314a2198089dd, content=we cannot accept the manuscript for publication, but would be interested in considering a revised version that addresses these serious concerns.这一意思是大修吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04906564334, createdName=ms5000000011937101, createdTime=Fri Apr 12 07:05:33 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2208056, encodeId=63c12208056d4, content=偏重的研究方向：基因组学<br>经验分享：6月1日提交，submission状态，希望好运！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab498294868, createdName=ms7000000214967727, createdTime=Mon Jun 03 14:14:56 CST 2024, time=2024-06-03, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2198308, encodeId=3d5221983088d, content=4.7提交，今天还是Submission，更新接好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96c69031712, createdName=ms6000002090135599, createdTime=Sat Apr 13 20:26:12 CST 2024, time=2024-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2206509, encodeId=2e9d220650922, content=等的心急，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsmALpODGnWib5UaDNI6ztgdmKt9ib3ibKROqTEpGzjvlLbbTLHod3OMBdlb0fCVKtGlvodJCkmsL7Q/132, createdBy=d0d95098090, createdName=ms1469747388241577, createdTime=Sat May 25 07:30:36 CST 2024, time=2024-05-25, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2195546, encodeId=7d7c219554630, content=偏重的研究方向：眼科;角膜<br>经验分享：第一次尝试。<br>更新攒人品拉！<br>Initial Manuscript Review Started 26th Mar 24<br>Editor Assigned 25th Mar 24<br>Submission 20th Mar 24<br>希望可以顺利<br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f75577556, createdName=ms7000000088062990, createdTime=Tue Mar 26 22:21:39 CST 2024, time=2024-03-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189505, encodeId=052d218950581, content=Editor assigned已经持续5天了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84c19170672, createdName=ms9000000584736868, createdTime=Mon Feb 26 19:54:36 CST 2024, time=2024-02-26, status=1, ipAttribution=慕尼黑), GetPortalCommentsPageByObjectIdResponse(id=2201987, encodeId=d607220198e99, content=目前的进度：<br>Initial Manuscript Review Started 30th Apr 24<br>Editor Assigned 25th Apr 24<br>Submission 17th Apr 24<br>还是不太搞得懂这个杂志的外审是哪个阶段啊？这个initial review算吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c9e8711556, createdName=ms3000002086500682, createdTime=Mon May 06 11:46:59 CST 2024, time=2024-05-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206135, encodeId=94122206135f2, content=审稿速度:24.0 | 投稿命中率:25.0<br>偏重的研究方向：昆虫共生菌<br>经验分享：Initial Manuscript Review Started 14th May 24<br>Editor Assigned 8th May 24<br>Submission 26th Apr 24<br>马上一个月了，请问intital manuscript review started持续十天是不是要悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d1e9163807, createdName=ms4000001806408431, createdTime=Thu May 23 09:08:10 CST 2024, time=2024-05-23, status=1, ipAttribution=浙江省)]
    2024-04-13 ms6000002090135599 来自浙江省

    4.7提交，今天还是Submission，更新接好运

    12

    展开12条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2204152, encodeId=93da2204152fb, content=请问大家一般是几个审稿人呀？一定要3个审稿人的意见编辑才会做决定吗？我在research square上看到3月份邀请了5个审稿人，2个同意并审完了（1个3月底，1个4月初）但是现在5月份了状态还在under review，这里也没有显示review3 agree的信息。<br>Review <a href='/topic/show?id=1efd114362fc' target=_blank style='color:#2F92EE;'>#2 received<br>Review #</a>1 received<br>Reviewer <a href='/topic/show?id=24c6114363d5' target=_blank style='color:#2F92EE;'>#2 agreed<br>Reviewer #</a>1 agreed<br>5 reviewer(s) invited<br>Invitations sent on 13 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=7, topicName=null, topicId=null, topicList=[TopicDto(id=114362, encryptionId=1efd114362fc, topicName=2 received<br>Review ), TopicDto(id=114363, encryptionId=24c6114363d5, topicName=2 agreed<br>Reviewer )], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86182534474, createdName=流离岁月, createdTime=Sat May 11 21:50:44 CST 2024, time=2024-05-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1247789, encodeId=32eb124e78951, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：第二轮<br>Waiting for Revision 6th Sep 22<br>Decision Made 6th Sep 22<br>Editor Review Started 14th Jul 22<br>Initial Manuscript Review Started 13th Jul 22<br>Editor Assigned 13th Jul 22<br>Submission 11th Jul 22<br>第一轮<br>Revision Received 11th Jul 22<br>Waiting for Revision 26th May 22<br>Decision Made 25th May 22<br>Editor Review Started 7th Apr 22<br>Initial Manuscript Review Started 28th Mar 22<br>Editor Assigned 25th Mar 22<br>Submission 23rd Mar 22<br><br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06461617618, createdName=keepworking, createdTime=Wed Sep 07 22:39:09 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198089, encodeId=314a2198089dd, content=we cannot accept the manuscript for publication, but would be interested in considering a revised version that addresses these serious concerns.这一意思是大修吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04906564334, createdName=ms5000000011937101, createdTime=Fri Apr 12 07:05:33 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2208056, encodeId=63c12208056d4, content=偏重的研究方向：基因组学<br>经验分享：6月1日提交，submission状态，希望好运！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab498294868, createdName=ms7000000214967727, createdTime=Mon Jun 03 14:14:56 CST 2024, time=2024-06-03, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2198308, encodeId=3d5221983088d, content=4.7提交，今天还是Submission，更新接好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96c69031712, createdName=ms6000002090135599, createdTime=Sat Apr 13 20:26:12 CST 2024, time=2024-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2206509, encodeId=2e9d220650922, content=等的心急，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsmALpODGnWib5UaDNI6ztgdmKt9ib3ibKROqTEpGzjvlLbbTLHod3OMBdlb0fCVKtGlvodJCkmsL7Q/132, createdBy=d0d95098090, createdName=ms1469747388241577, createdTime=Sat May 25 07:30:36 CST 2024, time=2024-05-25, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2195546, encodeId=7d7c219554630, content=偏重的研究方向：眼科;角膜<br>经验分享：第一次尝试。<br>更新攒人品拉！<br>Initial Manuscript Review Started 26th Mar 24<br>Editor Assigned 25th Mar 24<br>Submission 20th Mar 24<br>希望可以顺利<br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f75577556, createdName=ms7000000088062990, createdTime=Tue Mar 26 22:21:39 CST 2024, time=2024-03-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189505, encodeId=052d218950581, content=Editor assigned已经持续5天了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84c19170672, createdName=ms9000000584736868, createdTime=Mon Feb 26 19:54:36 CST 2024, time=2024-02-26, status=1, ipAttribution=慕尼黑), GetPortalCommentsPageByObjectIdResponse(id=2201987, encodeId=d607220198e99, content=目前的进度：<br>Initial Manuscript Review Started 30th Apr 24<br>Editor Assigned 25th Apr 24<br>Submission 17th Apr 24<br>还是不太搞得懂这个杂志的外审是哪个阶段啊？这个initial review算吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c9e8711556, createdName=ms3000002086500682, createdTime=Mon May 06 11:46:59 CST 2024, time=2024-05-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206135, encodeId=94122206135f2, content=审稿速度:24.0 | 投稿命中率:25.0<br>偏重的研究方向：昆虫共生菌<br>经验分享：Initial Manuscript Review Started 14th May 24<br>Editor Assigned 8th May 24<br>Submission 26th Apr 24<br>马上一个月了，请问intital manuscript review started持续十天是不是要悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d1e9163807, createdName=ms4000001806408431, createdTime=Thu May 23 09:08:10 CST 2024, time=2024-05-23, status=1, ipAttribution=浙江省)]
    2024-05-25 ms1469747388241577 来自辽宁省

    等的心急，太慢了

    2

    展开2条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2204152, encodeId=93da2204152fb, content=请问大家一般是几个审稿人呀？一定要3个审稿人的意见编辑才会做决定吗？我在research square上看到3月份邀请了5个审稿人，2个同意并审完了（1个3月底，1个4月初）但是现在5月份了状态还在under review，这里也没有显示review3 agree的信息。<br>Review <a href='/topic/show?id=1efd114362fc' target=_blank style='color:#2F92EE;'>#2 received<br>Review #</a>1 received<br>Reviewer <a href='/topic/show?id=24c6114363d5' target=_blank style='color:#2F92EE;'>#2 agreed<br>Reviewer #</a>1 agreed<br>5 reviewer(s) invited<br>Invitations sent on 13 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=7, topicName=null, topicId=null, topicList=[TopicDto(id=114362, encryptionId=1efd114362fc, topicName=2 received<br>Review ), TopicDto(id=114363, encryptionId=24c6114363d5, topicName=2 agreed<br>Reviewer )], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86182534474, createdName=流离岁月, createdTime=Sat May 11 21:50:44 CST 2024, time=2024-05-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1247789, encodeId=32eb124e78951, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：第二轮<br>Waiting for Revision 6th Sep 22<br>Decision Made 6th Sep 22<br>Editor Review Started 14th Jul 22<br>Initial Manuscript Review Started 13th Jul 22<br>Editor Assigned 13th Jul 22<br>Submission 11th Jul 22<br>第一轮<br>Revision Received 11th Jul 22<br>Waiting for Revision 26th May 22<br>Decision Made 25th May 22<br>Editor Review Started 7th Apr 22<br>Initial Manuscript Review Started 28th Mar 22<br>Editor Assigned 25th Mar 22<br>Submission 23rd Mar 22<br><br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06461617618, createdName=keepworking, createdTime=Wed Sep 07 22:39:09 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198089, encodeId=314a2198089dd, content=we cannot accept the manuscript for publication, but would be interested in considering a revised version that addresses these serious concerns.这一意思是大修吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04906564334, createdName=ms5000000011937101, createdTime=Fri Apr 12 07:05:33 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2208056, encodeId=63c12208056d4, content=偏重的研究方向：基因组学<br>经验分享：6月1日提交，submission状态，希望好运！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab498294868, createdName=ms7000000214967727, createdTime=Mon Jun 03 14:14:56 CST 2024, time=2024-06-03, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2198308, encodeId=3d5221983088d, content=4.7提交，今天还是Submission，更新接好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96c69031712, createdName=ms6000002090135599, createdTime=Sat Apr 13 20:26:12 CST 2024, time=2024-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2206509, encodeId=2e9d220650922, content=等的心急，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsmALpODGnWib5UaDNI6ztgdmKt9ib3ibKROqTEpGzjvlLbbTLHod3OMBdlb0fCVKtGlvodJCkmsL7Q/132, createdBy=d0d95098090, createdName=ms1469747388241577, createdTime=Sat May 25 07:30:36 CST 2024, time=2024-05-25, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2195546, encodeId=7d7c219554630, content=偏重的研究方向：眼科;角膜<br>经验分享：第一次尝试。<br>更新攒人品拉！<br>Initial Manuscript Review Started 26th Mar 24<br>Editor Assigned 25th Mar 24<br>Submission 20th Mar 24<br>希望可以顺利<br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f75577556, createdName=ms7000000088062990, createdTime=Tue Mar 26 22:21:39 CST 2024, time=2024-03-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189505, encodeId=052d218950581, content=Editor assigned已经持续5天了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84c19170672, createdName=ms9000000584736868, createdTime=Mon Feb 26 19:54:36 CST 2024, time=2024-02-26, status=1, ipAttribution=慕尼黑), GetPortalCommentsPageByObjectIdResponse(id=2201987, encodeId=d607220198e99, content=目前的进度：<br>Initial Manuscript Review Started 30th Apr 24<br>Editor Assigned 25th Apr 24<br>Submission 17th Apr 24<br>还是不太搞得懂这个杂志的外审是哪个阶段啊？这个initial review算吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c9e8711556, createdName=ms3000002086500682, createdTime=Mon May 06 11:46:59 CST 2024, time=2024-05-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206135, encodeId=94122206135f2, content=审稿速度:24.0 | 投稿命中率:25.0<br>偏重的研究方向：昆虫共生菌<br>经验分享：Initial Manuscript Review Started 14th May 24<br>Editor Assigned 8th May 24<br>Submission 26th Apr 24<br>马上一个月了，请问intital manuscript review started持续十天是不是要悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d1e9163807, createdName=ms4000001806408431, createdTime=Thu May 23 09:08:10 CST 2024, time=2024-05-23, status=1, ipAttribution=浙江省)]
    2024-03-26 ms7000000088062990 来自北京

    偏重的研究方向：眼科;角膜
    经验分享：第一次尝试。
    更新攒人品拉！
    Initial Manuscript Review Started 26th Mar 24
    Editor Assigned 25th Mar 24
    Submission 20th Mar 24
    希望可以顺利

    8

    展开8条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2204152, encodeId=93da2204152fb, content=请问大家一般是几个审稿人呀？一定要3个审稿人的意见编辑才会做决定吗？我在research square上看到3月份邀请了5个审稿人，2个同意并审完了（1个3月底，1个4月初）但是现在5月份了状态还在under review，这里也没有显示review3 agree的信息。<br>Review <a href='/topic/show?id=1efd114362fc' target=_blank style='color:#2F92EE;'>#2 received<br>Review #</a>1 received<br>Reviewer <a href='/topic/show?id=24c6114363d5' target=_blank style='color:#2F92EE;'>#2 agreed<br>Reviewer #</a>1 agreed<br>5 reviewer(s) invited<br>Invitations sent on 13 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=7, topicName=null, topicId=null, topicList=[TopicDto(id=114362, encryptionId=1efd114362fc, topicName=2 received<br>Review ), TopicDto(id=114363, encryptionId=24c6114363d5, topicName=2 agreed<br>Reviewer )], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86182534474, createdName=流离岁月, createdTime=Sat May 11 21:50:44 CST 2024, time=2024-05-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1247789, encodeId=32eb124e78951, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：第二轮<br>Waiting for Revision 6th Sep 22<br>Decision Made 6th Sep 22<br>Editor Review Started 14th Jul 22<br>Initial Manuscript Review Started 13th Jul 22<br>Editor Assigned 13th Jul 22<br>Submission 11th Jul 22<br>第一轮<br>Revision Received 11th Jul 22<br>Waiting for Revision 26th May 22<br>Decision Made 25th May 22<br>Editor Review Started 7th Apr 22<br>Initial Manuscript Review Started 28th Mar 22<br>Editor Assigned 25th Mar 22<br>Submission 23rd Mar 22<br><br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06461617618, createdName=keepworking, createdTime=Wed Sep 07 22:39:09 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198089, encodeId=314a2198089dd, content=we cannot accept the manuscript for publication, but would be interested in considering a revised version that addresses these serious concerns.这一意思是大修吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04906564334, createdName=ms5000000011937101, createdTime=Fri Apr 12 07:05:33 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2208056, encodeId=63c12208056d4, content=偏重的研究方向：基因组学<br>经验分享：6月1日提交，submission状态，希望好运！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab498294868, createdName=ms7000000214967727, createdTime=Mon Jun 03 14:14:56 CST 2024, time=2024-06-03, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2198308, encodeId=3d5221983088d, content=4.7提交，今天还是Submission，更新接好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96c69031712, createdName=ms6000002090135599, createdTime=Sat Apr 13 20:26:12 CST 2024, time=2024-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2206509, encodeId=2e9d220650922, content=等的心急，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsmALpODGnWib5UaDNI6ztgdmKt9ib3ibKROqTEpGzjvlLbbTLHod3OMBdlb0fCVKtGlvodJCkmsL7Q/132, createdBy=d0d95098090, createdName=ms1469747388241577, createdTime=Sat May 25 07:30:36 CST 2024, time=2024-05-25, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2195546, encodeId=7d7c219554630, content=偏重的研究方向：眼科;角膜<br>经验分享：第一次尝试。<br>更新攒人品拉！<br>Initial Manuscript Review Started 26th Mar 24<br>Editor Assigned 25th Mar 24<br>Submission 20th Mar 24<br>希望可以顺利<br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f75577556, createdName=ms7000000088062990, createdTime=Tue Mar 26 22:21:39 CST 2024, time=2024-03-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189505, encodeId=052d218950581, content=Editor assigned已经持续5天了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84c19170672, createdName=ms9000000584736868, createdTime=Mon Feb 26 19:54:36 CST 2024, time=2024-02-26, status=1, ipAttribution=慕尼黑), GetPortalCommentsPageByObjectIdResponse(id=2201987, encodeId=d607220198e99, content=目前的进度：<br>Initial Manuscript Review Started 30th Apr 24<br>Editor Assigned 25th Apr 24<br>Submission 17th Apr 24<br>还是不太搞得懂这个杂志的外审是哪个阶段啊？这个initial review算吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c9e8711556, createdName=ms3000002086500682, createdTime=Mon May 06 11:46:59 CST 2024, time=2024-05-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206135, encodeId=94122206135f2, content=审稿速度:24.0 | 投稿命中率:25.0<br>偏重的研究方向：昆虫共生菌<br>经验分享：Initial Manuscript Review Started 14th May 24<br>Editor Assigned 8th May 24<br>Submission 26th Apr 24<br>马上一个月了，请问intital manuscript review started持续十天是不是要悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d1e9163807, createdName=ms4000001806408431, createdTime=Thu May 23 09:08:10 CST 2024, time=2024-05-23, status=1, ipAttribution=浙江省)]
    2024-02-26 ms9000000584736868 来自慕尼黑

    Editor assigned已经持续5天了……

    5

    展开5条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2204152, encodeId=93da2204152fb, content=请问大家一般是几个审稿人呀？一定要3个审稿人的意见编辑才会做决定吗？我在research square上看到3月份邀请了5个审稿人，2个同意并审完了（1个3月底，1个4月初）但是现在5月份了状态还在under review，这里也没有显示review3 agree的信息。<br>Review <a href='/topic/show?id=1efd114362fc' target=_blank style='color:#2F92EE;'>#2 received<br>Review #</a>1 received<br>Reviewer <a href='/topic/show?id=24c6114363d5' target=_blank style='color:#2F92EE;'>#2 agreed<br>Reviewer #</a>1 agreed<br>5 reviewer(s) invited<br>Invitations sent on 13 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=7, topicName=null, topicId=null, topicList=[TopicDto(id=114362, encryptionId=1efd114362fc, topicName=2 received<br>Review ), TopicDto(id=114363, encryptionId=24c6114363d5, topicName=2 agreed<br>Reviewer )], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86182534474, createdName=流离岁月, createdTime=Sat May 11 21:50:44 CST 2024, time=2024-05-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1247789, encodeId=32eb124e78951, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：第二轮<br>Waiting for Revision 6th Sep 22<br>Decision Made 6th Sep 22<br>Editor Review Started 14th Jul 22<br>Initial Manuscript Review Started 13th Jul 22<br>Editor Assigned 13th Jul 22<br>Submission 11th Jul 22<br>第一轮<br>Revision Received 11th Jul 22<br>Waiting for Revision 26th May 22<br>Decision Made 25th May 22<br>Editor Review Started 7th Apr 22<br>Initial Manuscript Review Started 28th Mar 22<br>Editor Assigned 25th Mar 22<br>Submission 23rd Mar 22<br><br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06461617618, createdName=keepworking, createdTime=Wed Sep 07 22:39:09 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198089, encodeId=314a2198089dd, content=we cannot accept the manuscript for publication, but would be interested in considering a revised version that addresses these serious concerns.这一意思是大修吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04906564334, createdName=ms5000000011937101, createdTime=Fri Apr 12 07:05:33 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2208056, encodeId=63c12208056d4, content=偏重的研究方向：基因组学<br>经验分享：6月1日提交，submission状态，希望好运！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab498294868, createdName=ms7000000214967727, createdTime=Mon Jun 03 14:14:56 CST 2024, time=2024-06-03, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2198308, encodeId=3d5221983088d, content=4.7提交，今天还是Submission，更新接好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96c69031712, createdName=ms6000002090135599, createdTime=Sat Apr 13 20:26:12 CST 2024, time=2024-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2206509, encodeId=2e9d220650922, content=等的心急，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsmALpODGnWib5UaDNI6ztgdmKt9ib3ibKROqTEpGzjvlLbbTLHod3OMBdlb0fCVKtGlvodJCkmsL7Q/132, createdBy=d0d95098090, createdName=ms1469747388241577, createdTime=Sat May 25 07:30:36 CST 2024, time=2024-05-25, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2195546, encodeId=7d7c219554630, content=偏重的研究方向：眼科;角膜<br>经验分享：第一次尝试。<br>更新攒人品拉！<br>Initial Manuscript Review Started 26th Mar 24<br>Editor Assigned 25th Mar 24<br>Submission 20th Mar 24<br>希望可以顺利<br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f75577556, createdName=ms7000000088062990, createdTime=Tue Mar 26 22:21:39 CST 2024, time=2024-03-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189505, encodeId=052d218950581, content=Editor assigned已经持续5天了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84c19170672, createdName=ms9000000584736868, createdTime=Mon Feb 26 19:54:36 CST 2024, time=2024-02-26, status=1, ipAttribution=慕尼黑), GetPortalCommentsPageByObjectIdResponse(id=2201987, encodeId=d607220198e99, content=目前的进度：<br>Initial Manuscript Review Started 30th Apr 24<br>Editor Assigned 25th Apr 24<br>Submission 17th Apr 24<br>还是不太搞得懂这个杂志的外审是哪个阶段啊？这个initial review算吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c9e8711556, createdName=ms3000002086500682, createdTime=Mon May 06 11:46:59 CST 2024, time=2024-05-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206135, encodeId=94122206135f2, content=审稿速度:24.0 | 投稿命中率:25.0<br>偏重的研究方向：昆虫共生菌<br>经验分享：Initial Manuscript Review Started 14th May 24<br>Editor Assigned 8th May 24<br>Submission 26th Apr 24<br>马上一个月了，请问intital manuscript review started持续十天是不是要悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d1e9163807, createdName=ms4000001806408431, createdTime=Thu May 23 09:08:10 CST 2024, time=2024-05-23, status=1, ipAttribution=浙江省)]
    2024-05-06 ms3000002086500682 来自北京

    目前的进度：
    Initial Manuscript Review Started 30th Apr 24
    Editor Assigned 25th Apr 24
    Submission 17th Apr 24
    还是不太搞得懂这个杂志的外审是哪个阶段啊？这个initial review算吗？

    5

    展开5条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2204152, encodeId=93da2204152fb, content=请问大家一般是几个审稿人呀？一定要3个审稿人的意见编辑才会做决定吗？我在research square上看到3月份邀请了5个审稿人，2个同意并审完了（1个3月底，1个4月初）但是现在5月份了状态还在under review，这里也没有显示review3 agree的信息。<br>Review <a href='/topic/show?id=1efd114362fc' target=_blank style='color:#2F92EE;'>#2 received<br>Review #</a>1 received<br>Reviewer <a href='/topic/show?id=24c6114363d5' target=_blank style='color:#2F92EE;'>#2 agreed<br>Reviewer #</a>1 agreed<br>5 reviewer(s) invited<br>Invitations sent on 13 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=7, topicName=null, topicId=null, topicList=[TopicDto(id=114362, encryptionId=1efd114362fc, topicName=2 received<br>Review ), TopicDto(id=114363, encryptionId=24c6114363d5, topicName=2 agreed<br>Reviewer )], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86182534474, createdName=流离岁月, createdTime=Sat May 11 21:50:44 CST 2024, time=2024-05-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1247789, encodeId=32eb124e78951, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：第二轮<br>Waiting for Revision 6th Sep 22<br>Decision Made 6th Sep 22<br>Editor Review Started 14th Jul 22<br>Initial Manuscript Review Started 13th Jul 22<br>Editor Assigned 13th Jul 22<br>Submission 11th Jul 22<br>第一轮<br>Revision Received 11th Jul 22<br>Waiting for Revision 26th May 22<br>Decision Made 25th May 22<br>Editor Review Started 7th Apr 22<br>Initial Manuscript Review Started 28th Mar 22<br>Editor Assigned 25th Mar 22<br>Submission 23rd Mar 22<br><br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06461617618, createdName=keepworking, createdTime=Wed Sep 07 22:39:09 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198089, encodeId=314a2198089dd, content=we cannot accept the manuscript for publication, but would be interested in considering a revised version that addresses these serious concerns.这一意思是大修吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04906564334, createdName=ms5000000011937101, createdTime=Fri Apr 12 07:05:33 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2208056, encodeId=63c12208056d4, content=偏重的研究方向：基因组学<br>经验分享：6月1日提交，submission状态，希望好运！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab498294868, createdName=ms7000000214967727, createdTime=Mon Jun 03 14:14:56 CST 2024, time=2024-06-03, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2198308, encodeId=3d5221983088d, content=4.7提交，今天还是Submission，更新接好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96c69031712, createdName=ms6000002090135599, createdTime=Sat Apr 13 20:26:12 CST 2024, time=2024-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2206509, encodeId=2e9d220650922, content=等的心急，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsmALpODGnWib5UaDNI6ztgdmKt9ib3ibKROqTEpGzjvlLbbTLHod3OMBdlb0fCVKtGlvodJCkmsL7Q/132, createdBy=d0d95098090, createdName=ms1469747388241577, createdTime=Sat May 25 07:30:36 CST 2024, time=2024-05-25, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2195546, encodeId=7d7c219554630, content=偏重的研究方向：眼科;角膜<br>经验分享：第一次尝试。<br>更新攒人品拉！<br>Initial Manuscript Review Started 26th Mar 24<br>Editor Assigned 25th Mar 24<br>Submission 20th Mar 24<br>希望可以顺利<br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f75577556, createdName=ms7000000088062990, createdTime=Tue Mar 26 22:21:39 CST 2024, time=2024-03-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189505, encodeId=052d218950581, content=Editor assigned已经持续5天了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84c19170672, createdName=ms9000000584736868, createdTime=Mon Feb 26 19:54:36 CST 2024, time=2024-02-26, status=1, ipAttribution=慕尼黑), GetPortalCommentsPageByObjectIdResponse(id=2201987, encodeId=d607220198e99, content=目前的进度：<br>Initial Manuscript Review Started 30th Apr 24<br>Editor Assigned 25th Apr 24<br>Submission 17th Apr 24<br>还是不太搞得懂这个杂志的外审是哪个阶段啊？这个initial review算吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c9e8711556, createdName=ms3000002086500682, createdTime=Mon May 06 11:46:59 CST 2024, time=2024-05-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206135, encodeId=94122206135f2, content=审稿速度:24.0 | 投稿命中率:25.0<br>偏重的研究方向：昆虫共生菌<br>经验分享：Initial Manuscript Review Started 14th May 24<br>Editor Assigned 8th May 24<br>Submission 26th Apr 24<br>马上一个月了，请问intital manuscript review started持续十天是不是要悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d1e9163807, createdName=ms4000001806408431, createdTime=Thu May 23 09:08:10 CST 2024, time=2024-05-23, status=1, ipAttribution=浙江省)]
    2024-05-23 ms4000001806408431 来自浙江省

    审稿速度:24.0 | 投稿命中率:25.0
    偏重的研究方向：昆虫共生菌
    经验分享：Initial Manuscript Review Started 14th May 24
    Editor Assigned 8th May 24
    Submission 26th Apr 24
    马上一个月了，请问intital manuscript review started持续十天是不是要悲剧了

    0

共186条页码: 1/19页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分